# Biolitec - Phlebology

> Biolitec - Phlebology (iPhone/iPad app by fr financial relations gmbh.)

- Source: https://appshunter.io/ios/app/biolitec/id6483210809 (this page in markdown: same URL + `.md`)
- Developer: [fr financial relations gmbh](https://appshunter.io/developer/1537527575)
- Category: Medical, Business
- Price: Free
- Age rating: 4+
- Requires: iOS 11.0 · 28 MB
- Languages: English
- Released: 2024-04-08
- Data updated: 2025-12-04
- User reviews in markdown: https://appshunter.io/ios/app/biolitec/id6483210809/reviews.md

## What is Biolitec?

The German-English Biolitec Phlebology App supports specialists with the latest know-how in minimally invasive laser surgery. Here doctors will find studies, videos, trade fairs & workshops, news and direct contact to the sales force. There is also a closed Doctors Forum for the exchange of interesting photos, videos, links and reports.


## Version history (last 1 release)

### 1.0 — 2024-04-08

No release notes.

## Apps similar to Biolitec

| App | Rating | Price | Category |
| --- | --- | --- | --- |
| [ÖGARI Prämed](https://appshunter.io/ios/app/gari-prmed/id6736619771) | — | Free | Medical |
| [Arzneimittel (Weleda AG, D)](https://appshunter.io/ios/app/arzneimittel-weleda-ag-d/id1461761086) | — | Free | Medical |
| [Hyperhidrose Hyperhidrosis](https://appshunter.io/ios/app/hyperhidrose-hyperhidrosis/id1166160401) | — | Free | Medical |
| [Arzeko](https://appshunter.io/ios/app/arzeko/id1276986922) | — | Free | Medical |
| [ICD-10 CM Codes 2022 Reference](https://appshunter.io/ios/app/icd/id415731352) | 4.0 (4) | Free | Medical |

## More apps by fr financial relations gmbh

- [Biolitec - Procto](https://appshunter.io/ios/app/biolitec/id6529536426)

All apps by fr financial relations gmbh: https://appshunter.io/developer/1537527575

---

*Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2025-12-04.*
